Cargando…

Real life management of patients hospitalized with multiple myeloma in France

BACKGROUND: Patients with multiple myeloma included in prospective clinical trials are highly selected and therefore are expected not to be representative of the entire patient population. Additionally recommendations based on literature data and randomized trials are not systematically implemented...

Descripción completa

Detalles Bibliográficos
Autores principales:	Dumontet, Charles, Couray-Targe, Sandrine, Teisseire, Marion, Karlin, Lionel, Maucort-Boulch, Delphine
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2018
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5929551/ https://www.ncbi.nlm.nih.gov/pubmed/29715281 http://dx.doi.org/10.1371/journal.pone.0196596

Ejemplares similares

Mixed method versus full top-down microcosting for organ recovery cost assessment in a French hospital group
por: Hrifach, Abdelbaste, et al.
Publicado: (2016)

National cost study versus hospital cost accounting for organ recovery cost assessment in a French hospital group
por: Hrifach, Abdelbaste, et al.
Publicado: (2018)

Comparative optimism in models involving both classical clinical and gene expression information
por: Truntzer, Caroline, et al.
Publicado: (2008)

Multiple myeloma: patient outcomes in real‐world practice
por: Yong, Kwee, et al.
Publicado: (2016)

Worrying decrease in hospital admissions for myocardial infarction during the COVID-19 pandemic
por: Lantelme, Pierre, et al.
Publicado: (2020)

Assessment of Patient Reported Outcomes (PROs) in Outpatients Taking Oral Anticancer Drugs Included in the Real-Life Oncoral Program
por: Collomb, Bastien, et al.
Publicado: (2022)

World‐wide relative contribution of hepatitis B and C viruses in hepatocellular carcinoma
por: de Martel, Catherine, et al.
Publicado: (2015)

Malondialdehyde Adduct to Hemoglobin: A New Marker of Oxidative Stress Suitable for Full-Term and Preterm Neonates
por: Cipierre, Cécile, et al.
Publicado: (2013)

Adduct of Malondialdehyde to Hemoglobin: A New Marker of Oxidative Stress That Is Associated with Significant Morbidity in Preterm Infants
por: Cipierre, Cécile, et al.
Publicado: (2013)

Health-related quality of life in cancer immunotherapy: a systematic perspective, using causal loop diagrams
por: Beaulieu, Elizabeth, et al.
Publicado: (2022)

Risk factors of mild rectal bleeding in very low birth weight infants: a case control study
por: Oulmaati, Abdallah, et al.
Publicado: (2013)

Epidemiology, Mortality and Healthcare Resource Utilization Associated With Systemic Sclerosis-Associated Interstitial Lung Disease in France
por: Cottin, Vincent, et al.
Publicado: (2021)

Vascular Events and Carotid Atherosclerosis: A 5-Year Prospective Cohort Study in Patients with Type 2 Diabetes and a Contemporary Cardiovascular Prevention Treatment
por: Vouillarmet, Julien, et al.
Publicado: (2019)

Estimates of epidemiology, mortality and disease burden associated with progressive fibrosing interstitial lung disease in France (the PROGRESS study)
por: Nasser, Mouhamad, et al.
Publicado: (2021)

Molecular Evidence of Interhuman Transmission of Pneumocystis Pneumonia among Renal Transplant Recipients Hospitalized with HIV-Infected Patients
por: Rabodonirina, Meja, et al.
Publicado: (2004)

Decreased survival in patients treated by chemotherapy after targeted therapy compared to immunotherapy in metastatic melanoma
por: Mangin, Marie‐Alix, et al.
Publicado: (2021)

The increasing age of respiratory syncytial virus-related hospitalisation during COVID-19 pandemic in Lyon was associated with reduced hospitalisation costs
por: Roy, Álvaro, et al.
Publicado: (2023)

Hospitalization at the end of life in patients with multiple myeloma
por: Abbasi, Saqib, et al.
Publicado: (2021)

Multiple Myeloma in 2023 Ways: From Trials to Real Life
por: Fazio, Manlio, et al.
Publicado: (2023)

Inhibition of IGF-1 Signalling Enhances the Apoptotic Effect of AS602868, an IKK2 Inhibitor, in Multiple Myeloma Cell Lines
por: Tagoug, Ines, et al.
Publicado: (2011)

Eye bank prepared versus surgeon cut endothelial graft tissue for Descemet membrane endothelial keratoplasty: An observational study
por: Regnier, Marie, et al.
Publicado: (2017)

Applicability of Pulse Pressure Variation during Unstable Hemodynamic Events in the Intensive Care Unit: A Five-Day Prospective Multicenter Study
por: Delannoy, Bertrand, et al.
Publicado: (2016)

Incidence of Cystoid Macular Edema After Descemet Membrane Endothelial Keratoplasty
por: Kocaba, Viridiana, et al.
Publicado: (2018)

Left ventricular ejection fraction decrease related to BRAF and/or MEK inhibitors in metastatic melanoma patients: A retrospective analysis
por: Berger, Mathilde, et al.
Publicado: (2020)

Effect of periodontal treatment on the glomerular filtration rate, reduction of inflammatory markers and mortality in patients with chronic kidney disease: A systematic review
por: Delbove, Théo, et al.
Publicado: (2021)

Real-world study of the efficacy and safety of belantamab mafodotin (GSK2857916) in relapsed or refractory multiple myeloma based on data from the nominative ATU in France: the IFM 2020-04 study
por: Talbot, Alexis, et al.
Publicado: (2023)

Metapopulation ecology links antibiotic resistance, consumption, and patient transfers in a network of hospital wards
por: Shapiro, Julie Teresa, et al.
Publicado: (2020)

Adult-Onset Still Disease: Manifestations, Treatment, Outcome, and Prognostic Factors in 57 Patients
por: Gerfaud-Valentin, Mathieu, et al.
Publicado: (2014)

Development and Validation of a Bayesian Network for Supporting the Etiological Diagnosis of Uveitis
por: Jamilloux, Yvan, et al.
Publicado: (2021)

PB2126: RETROSPECTIVE REAL LIFE STUDY OF MULTIPLE MYELOMA STATUS AT DEATH.
por: Pérez, Mónica Fernández, et al.
Publicado: (2023)

Large-scale real-life analysis of survival and usage of therapies in multiple myeloma
por: Lopez-Muñoz, N., et al.
Publicado: (2023)

Real‐world treatment patterns and outcomes in non‐transplant newly diagnosed multiple Myeloma in France, Germany, Italy, and the United Kingdom
por: Mohty, Mohamad, et al.
Publicado: (2020)

Genetically determined telomere length and multiple myeloma risk and outcome
por: Giaccherini, Matteo, et al.
Publicado: (2021)

Thrombin generation in newly diagnosed multiple myeloma during the first three cycles of treatment: An observational cohort study
por: Chalayer, Emilie, et al.
Publicado: (2018)

Diagnosis, risk factors and management of diabetes mellitus in HIV-infected persons in France: A real-life setting study
por: Kousignian, Isabelle, et al.
Publicado: (2021)

Correction: Large-scale real-life analysis of survival and usage of therapies in multiple myeloma
por: Lopez-Muñoz, N., et al.
Publicado: (2023)

Impact of catch-up human papillomavirus vaccination on cervical conization rate in a real-life population in France
por: Eliès, Antoine, et al.
Publicado: (2022)

Real-world effectiveness of ixazomib combined with lenalidomide and dexamethasone in relapsed/refractory multiple myeloma: the REMIX study
por: Macro, M., et al.
Publicado: (2023)

Carfilzomib, lenalidomide, and dexamethasone in relapsed refractory multiple myeloma: a prospective real-life experience of the Regional Tuscan Myeloma Network
por: Antonioli, Elisabetta, et al.
Publicado: (2023)

Relationship between discordant response to HAART, Tregs, immune activation and low-level viraemia
por: Saison, Julien, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_4djistu220l7tr6pv2e6bjllts